OBJECTIVE: To evaluate changes in visual acuity (VA) over time in patients with Leber congenital amaurosis (LCA) and mutations in the CEP290 gene. METHODS: Visual acuity was determined at the initial and most recent visits of 43 patients with LCA and CEP290 mutations. The main outcome measures included the best-corrected VA at the initial and most recent visits, as well as the correlation between age and VA. RESULTS: At the initial visit, 14 patients had measurable chart VA in the better-seeing eye, 25 patients had nonmeasurable chart VA, and 4 young patients did not have VA assessed. At the most recent visit, 15 patients had measurable chart VA and 28 had nonmeasurable chart VA. The average interval between the 2 visits was 10.4 years (range, 2-47 years). For patients with measurable chart VA, the median logMAR value at the initial visit (0.75; range, 0.10-2.30) and at the most recent visit (0.70; range, 0.10-2.00) did not differ significantly (P> .05). There was no significant relationship between VA and age. CONCLUSIONS: Patients with LCA and CEP290 mutations had a wide spectrum of VA that was not related to age or length of follow-up. Severe VA loss was observed in most, but not all, patients in the first decade. These data will help clinicians provide counseling on VA changes in patients with CEP290 mutations and could be of value for future treatment trials.
OBJECTIVE: To evaluate changes in visual acuity (VA) over time in patients with Leber congenital amaurosis (LCA) and mutations in the CEP290 gene. METHODS: Visual acuity was determined at the initial and most recent visits of 43 patients with LCA and CEP290 mutations. The main outcome measures included the best-corrected VA at the initial and most recent visits, as well as the correlation between age and VA. RESULTS: At the initial visit, 14 patients had measurable chart VA in the better-seeing eye, 25 patients had nonmeasurable chart VA, and 4 young patients did not have VA assessed. At the most recent visit, 15 patients had measurable chart VA and 28 had nonmeasurable chart VA. The average interval between the 2 visits was 10.4 years (range, 2-47 years). For patients with measurable chart VA, the median logMAR value at the initial visit (0.75; range, 0.10-2.30) and at the most recent visit (0.70; range, 0.10-2.00) did not differ significantly (P> .05). There was no significant relationship between VA and age. CONCLUSIONS:Patients with LCA and CEP290 mutations had a wide spectrum of VA that was not related to age or length of follow-up. Severe VA loss was observed in most, but not all, patients in the first decade. These data will help clinicians provide counseling on VA changes in patients with CEP290 mutations and could be of value for future treatment trials.
Authors: Enza Maria Valente; Jennifer L Silhavy; Francesco Brancati; Giuseppe Barrano; Suguna Rani Krishnaswami; Marco Castori; Madeline A Lancaster; Eugen Boltshauser; Loredana Boccone; Lihadh Al-Gazali; Elisa Fazzi; Sabrina Signorini; Carrie M Louie; Emanuele Bellacchio; Enrico Bertini; Bruno Dallapiccola; Joseph G Gleeson Journal: Nat Genet Date: 2006-05-07 Impact factor: 38.330
Authors: John A Sayer; Edgar A Otto; John F O'Toole; Gudrun Nurnberg; Michael A Kennedy; Christian Becker; Hans Christian Hennies; Juliana Helou; Massimo Attanasio; Blake V Fausett; Boris Utsch; Hemant Khanna; Yan Liu; Iain Drummond; Isao Kawakami; Takehiro Kusakabe; Motoyuki Tsuda; Li Ma; Hwankyu Lee; Ronald G Larson; Susan J Allen; Christopher J Wilkinson; Erich A Nigg; Chengchao Shou; Concepcion Lillo; David S Williams; Bernd Hoppe; Markus J Kemper; Thomas Neuhaus; Melissa A Parisi; Ian A Glass; Marianne Petry; Andreas Kispert; Joachim Gloy; Athina Ganner; Gerd Walz; Xueliang Zhu; Daniel Goldman; Peter Nurnberg; Anand Swaroop; Michel R Leroux; Friedhelm Hildebrandt Journal: Nat Genet Date: 2006-05-07 Impact factor: 38.330
Authors: Anneke I den Hollander; Robert K Koenekoop; Suzanne Yzer; Irma Lopez; Maarten L Arends; Krysta E J Voesenek; Marijke N Zonneveld; Tim M Strom; Thomas Meitinger; Han G Brunner; Carel B Hoyng; L Ingeborgh van den Born; Klaus Rohrschneider; Frans P M Cremers Journal: Am J Hum Genet Date: 2006-07-11 Impact factor: 11.025
Authors: S Grover; G A Fishman; R J Anderson; M S Tozatti; J R Heckenlively; R G Weleber; A O Edwards; J Brown Journal: Ophthalmology Date: 1999-09 Impact factor: 12.079
Authors: Artur V Cideciyan; Rivka A Rachel; Tomas S Aleman; Malgorzata Swider; Sharon B Schwartz; Alexander Sumaroka; Alejandro J Roman; Edwin M Stone; Samuel G Jacobson; Anand Swaroop Journal: Hum Mol Genet Date: 2011-01-18 Impact factor: 6.150
Authors: M M Sohocki; L S Sullivan; H A Mintz-Hittner; D Birch; J R Heckenlively; C L Freund; R R McInnes; S P Daiger Journal: Am J Hum Genet Date: 1998-11 Impact factor: 11.025
Authors: Frederick T Collison; Jason C Park; Gerald A Fishman; J Jason McAnany; Edwin M Stone Journal: Invest Ophthalmol Vis Sci Date: 2015-11 Impact factor: 4.799
Authors: Francesco Testa; Andrea Sodi; Sabrina Signorini; Valentina Di Iorio; Vittoria Murro; Raffaella Brunetti-Pierri; Enza Maria Valente; Marianthi Karali; Paolo Melillo; Sandro Banfi; Francesca Simonelli Journal: Invest Ophthalmol Vis Sci Date: 2021-07-01 Impact factor: 4.799
Authors: Katie X Li; Nicholas Carducci; Omar Moinuddin; Yunshu Zhou; David C Musch; David N Zacks; Cagri G Besirli; Thomas J Wubben Journal: Clin Ophthalmol Date: 2021-03-08
Authors: Shannon E Boye; Wei-Chieh Huang; Alejandro J Roman; Alexander Sumaroka; Sanford L Boye; Renee C Ryals; Melani B Olivares; Qing Ruan; Budd A Tucker; Edwin M Stone; Anand Swaroop; Artur V Cideciyan; William W Hauswirth; Samuel G Jacobson Journal: PLoS One Date: 2014-03-26 Impact factor: 3.240
Authors: John Pei-Wen Chiang; Tina Lamey; Terri McLaren; Jennifer A Thompson; Hannah Montgomery; John De Roach Journal: Expert Rev Mol Diagn Date: 2015-08-26 Impact factor: 5.225
Authors: Kalyan Dulla; Monica Aguila; Amelia Lane; Katarina Jovanovic; David A Parfitt; Iris Schulkens; Hee Lam Chan; Iris Schmidt; Wouter Beumer; Lars Vorthoren; Rob W J Collin; Alejandro Garanto; Lonneke Duijkers; Anna Brugulat-Panes; Ma'ayan Semo; Anthony A Vugler; Patricia Biasutto; Peter Adamson; Michael E Cheetham Journal: Mol Ther Nucleic Acids Date: 2018-07-23 Impact factor: 8.886
Authors: Leo Sheck; Wayne I L Davies; Phillip Moradi; Anthony G Robson; Neruban Kumaran; Alki C Liasis; Andrew R Webster; Anthony T Moore; Michel Michaelides Journal: Ophthalmology Date: 2018-02-03 Impact factor: 12.079